Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


19.08.2019

1 Am J Gastroenterol
2 Biochem Biophys Res Commun
5 BMC Cancer
1 BMC Gastroenterol
2 Clin Res Hepatol Gastroenterol
1 Dig Dis Sci
1 Endoscopy
1 Eur Radiol
2 Gastroenterology
1 Hepatology
2 J Gastroenterol Hepatol
1 Lancet
1 Oncogene
1 Radiology
12 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. CARRION AF, Martin P
    Renal Dysfunction in Cirrhotic Patients.
    Am J Gastroenterol. 2019 Aug 7. doi: 10.14309/ajg.0000000000000355.
    PubMed     Text format    


    Biochem Biophys Res Commun

  2. ZHAO G, Song Y, Dong L, Shi H, et al
    Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3beta/Wnt/beta-catenin signaling.
    Biochem Biophys Res Commun. 2019 Aug 5. pii: S0006-291X(19)31490.
    PubMed     Text format     Abstract available

  3. XIE W, Ma LL, Xu YQ, Wang BH, et al
    METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Biochem Biophys Res Commun. 2019 Aug 10. pii: S0006-291X(19)31520.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. CAO H, Xu Z, Wang J, Cigliano A, et al
    Functional role of SGK3 in PI3K/Pten driven liver tumor development.
    BMC Cancer. 2019;19:343.
    PubMed     Text format     Abstract available

  5. LV Y, Han X, Xu XF, Ji Y, et al
    Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    BMC Cancer. 2019;19:335.
    PubMed     Text format     Abstract available

  6. SAVCI-HEIJINK CD, Halfwerk H, Koster J, Horlings HM, et al
    A specific gene expression signature for visceral organ metastasis in breast cancer.
    BMC Cancer. 2019;19:333.
    PubMed     Text format     Abstract available

  7. MIKSAD RA, Ogasawara S, Xia F, Fellous M, et al
    Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study.
    BMC Cancer. 2019;19:795.
    PubMed     Text format     Abstract available

  8. HUANG FY, Wong DK, Tsui VW, Seto WK, et al
    Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
    BMC Cancer. 2019;19:789.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  9. DONG ZR, Xia YN, Zhao RY, Wu R, et al
    Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report.
    BMC Gastroenterol. 2019;19:142.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  10. SUH SW, Choi YS, Hong SA, Kang H, et al
    Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model.
    Clin Res Hepatol Gastroenterol. 2018 Mar 23. pii: S2210-7401(17)30268.
    PubMed     Text format     Abstract available

  11. HUNG TH, Lee HF, Tseng CW, Tsai CC, et al
    Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(17)30267.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  12. DONG Z, Liao B, Shen W, Sui C, et al
    Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2019 Aug 13. pii: 10.1007/s10620-019-05787.
    PubMed     Text format     Abstract available


    Endoscopy

  13. RAMOS-ZABALA F, Alzina-Perez A, Vasquez-Guerrero J, Garcia-Mayor M, et al
    Polypectomy of a giant sessile polyp in the hepatic flexure using scissor-type forceps and a gravity traction method to create a pseudo-peduncle.
    Endoscopy. 2019 Aug 9. doi: 10.1055/a-0978-4839.
    PubMed     Text format    


    Eur Radiol

  14. CHOURAQUI E, Leguilloux L, Dohan A, Gouya H, et al
    Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?
    Eur Radiol. 2019 Aug 13. pii: 10.1007/s00330-019-06391.
    PubMed     Text format     Abstract available


    Gastroenterology

  15. TEMMERMAN F, Nevens F
    Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story.
    Gastroenterology. 2019;157:298-299.
    PubMed     Text format    

  16. TAO H, Chen X
    The role of CXCR6 deficient Natural Killer T- and CD4 + T cells in hepatocarcinogenesis.
    Gastroenterology. 2019 Aug 7. pii: S0016-5085(19)41194.
    PubMed     Text format    


    Hepatology

  17. PATRA T, Meyer K, Ray RB, Ray R, et al
    Hepatitis C virus mediated inhibition of miR-181c activates ATM signaling and promotes hepatocyte growth.
    Hepatology. 2019 Aug 10. doi: 10.1002/hep.30893.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  18. FENG Q, Yao J
    Hepatobiliary and Pancreatic: common bile duct stones with situs inversus totalis.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14833.
    PubMed     Text format    

  19. PANDYA K, Liu K, Strasser SI
    Diaphragmatic paralysis after transarterial chemoembolization of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14834.
    PubMed     Text format    


    Lancet

  20. LOW ESL, Patwala K, Apostolov R
    Dyspnoea, clubbing, cirrhosis, and bubbles in both sides of the heart suggests hepatopulmonary syndrome.
    Lancet. 2019;394:510.
    PubMed     Text format    


    Oncogene

  21. SHANKARAIAH RC, Callegari E, Guerriero P, Rimessi A, et al
    Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0942.
    PubMed     Text format     Abstract available


    Radiology

  22. MIKHAIL AS, Pritchard WF, Negussie AH, Krishnasamy VP, et al
    Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.
    Radiology. 2018 Aug 14:172571. doi: 10.1148/radiol.2018172571.
    PubMed     Text format     Abstract available


    Transplant Proc

  23. SERIN A, Sahin T, Emek E, Arikan T, et al
    Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(19)30242.
    PubMed     Text format     Abstract available

  24. SOKMEN BK, Sabet S, Oz A, Server S, et al
    Value of Intravoxel Incoherent Motion for Hepatocellular Carcinoma Grading.
    Transplant Proc. 2019;51:1861-1866.
    PubMed     Text format     Abstract available

  25. MEYEROVICH G, Goykhman Y, Nakache R, Nachmany I, et al
    Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
    Transplant Proc. 2019;51:1867-1873.
    PubMed     Text format     Abstract available

  26. SKILL NJ, Butler J, O'Brien DC, Kays JK, et al
    Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma.
    Transplant Proc. 2019;51:1907-1912.
    PubMed     Text format     Abstract available

  27. REN SS, Xu LL, Wang P, Li L, et al
    Circadian Rhythms Have Effects on Surgical Outcomes of Liver Transplantation for Patients With Hepatocellular Carcinoma: A Retrospective Analysis of 147 Cases in a Single Center.
    Transplant Proc. 2019;51:1913-1919.
    PubMed     Text format     Abstract available

  28. SOTIROPOULOS GC, Malago M, Machairas N, Fouzas I, et al
    AGMA Score: A Novel Prognostic Score for Patients Undergoing Liver Transplant for Hepatocellular Carcinoma.
    Transplant Proc. 2019;51:1923-1925.
    PubMed     Text format     Abstract available

  29. SHI Y, Qiu X, Dai M, Zhang X, et al
    Hyperoside Attenuates Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Inhibiting Apoptosis in Rats.
    Transplant Proc. 2019;51:2051-2059.
    PubMed     Text format     Abstract available

  30. XIONG Y, Fan L, Tu Q, Peng G, et al
    Cytochrome b5 Interacts With Cytochrome C and Inhibits Hepatocyte Apoptosis in Brain-dead Rabbit Donors.
    Transplant Proc. 2019;51:2108-2115.
    PubMed     Text format     Abstract available

  31. SAHIN T, Arikan BT, Serin A, Emek E, et al
    The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31704.
    PubMed     Text format     Abstract available

  32. SAHIN T, Serin A, Emek E, Bozkurt B, et al
    Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31711.
    PubMed     Text format     Abstract available

  33. SERVER S, Sabet S, Yaghouti K, Namal E, et al
    Value of Imaging Findings in the Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31723.
    PubMed     Text format     Abstract available

  34. ADALI G, Bozkurt B, Ceyhan O, Server S, et al
    Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(19)30229.
    PubMed     Text format     Abstract available


    Transplantation

  35. SAEED N, Glass L, Sharma P, Shannon C, et al
    Incidence and Risks for Non Alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Review and Meta-analysis.
    Transplantation. 2019 Aug 12. doi: 10.1097/TP.0000000000002916.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: